查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1566843

輸尿管通路鞘套市場：按類型、最終用戶分類：2024-2033 年全球機會分析與產業預測

Ureteral Access Sheath Market By Type (Fr below 10, Fr 10-12, Fr 13-15) , By End User (Hospital, Specialty Clinics, Ambulatory Surgical Centers) : Global Opportunity Analysis and Industry Forecast, 2024-2033
出版日期: | 出版商: Allied Market Research | 英文 280 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

輸尿管通路鞘套市場

2023年輸尿管通路鞘套市值為12.936億美元，預計2035年將達到24.1246億美元，2024年至2035年的複合年成長率為5.31%。

輸尿管通路鞘套是泌尿系統手術中的重要設備，特別用於涉及泌尿道和腎臟的介入。輸尿管通路鞘套是一根軟性管，插入輸尿管，在輸尿管鏡檢查等微創手術過程中為其他器械（例如雷射或視鏡）創建通道。該鞘套允許重複插入和移除而不會損壞器械，這在需要多次干預或長時間手術的情況下非常有用。輸尿管通路鞘套可方便地進入腎臟和輸尿管，使泌尿系統能夠高精度、高效率地執行複雜的手術。研究表明，輸尿管通路鞘套透過促進手術期間的沖洗流出來降低術中腎內壓力和溫度。

腎結石市場的開拓、新興市場醫療基礎設施的改善以及微創手術的快速採用是輸尿管通路鞘套市場的主要驅動力。過去幾年，由於不健康飲食、肥胖、脫水和代謝紊亂的增加，腎結石病例激增。根據疾病管制與預防中心今年發布的一份情況說明書，美國約有 600 萬人美國腎結石。

然而，應用輸尿管通路鞘套非常複雜並且需要大量的訓練和實踐。不正確的安裝通常會導致嚴重的併發症，阻礙市場的開拓。此外，還有多種治療泌尿系統疾病的替代方法，例如不使用鞘套的腎內逆行手術，因此限制了它們的採用。相較之下，美國泌尿系統協會2024年（AUA2024）年會上展示的一張海報稱，術前給予Tamsulosin（一種放鬆前列腺和膀胱頸肌肉的藥物）可以改善腎功能，可以用於結石治療的輸尿管通路鞘套。

按部門審查

全球輸尿管通路鞘套市場按類型、最終用戶和地區細分。依類型分類，市場分為10Fr及以下、10-12Fr、13-15Fr。依最終使用者分為醫院、專科診所和門診手術中心。從區域來看，分析涵蓋北美、歐洲、亞太地區和拉丁美洲/中東/非洲。

主要發現

按類型分類，10Fr 及以下細分市場將在 2023 年佔據市場主導地位。

按最終用戶分類，專科診所細分市場將在 2023 年獲得較高的市場佔有率。

在北美，由於成熟的醫療保健系統和對研發的大量投資，市場強勁。

該報告可以客製化。

  • 監管指引
  • 根據客戶興趣加入公司簡介
  • 按國家或地區進行的附加分析 – 市場規模和預測
  • 擴大公司簡介列表
  • 歷史市場資料
  • 主要參與企業的詳細資料（Excel格式，包括位置、聯絡資訊、供應商/供應商網路等）

目錄

第1章簡介

第 2 章執行摘要

第3章 市場狀況

  • 市場定義和範圍
  • 主要發現
    • 關鍵投資機會
    • 關鍵成功策略
  • 波特五力分析
  • 市場動態
    • 促進因素
    • 抑制因素
    • 機會

第4章尿道通路鞘套市場：依類型

  • 市場概況
  • 10Fr以下
  • 10～12Fr
  • 13～15Fr

第5章輸尿管通路鞘套市場：依最終用戶分類

  • 市場概況
  • 醫院
  • 專科診所
  • 門診手術中心

第6章 尿道通路鞘套市場：依地區

  • 市場概況
  • 北美洲
    • 主要市場趨勢和機遇
    • 美國輸尿管通路鞘套市場
    • 加拿大輸尿管通路鞘套市場
    • 墨西哥輸尿管通路鞘套市場
  • 歐洲
    • 主要市場趨勢和機遇
    • 德國輸尿管通路鞘套市場
    • 法國輸尿管通路鞘套市場
    • 英國輸尿管通路鞘套市場
    • 義大利輸尿管通路鞘套市場
    • 西班牙輸尿管通路鞘套市場
    • 其他歐洲輸尿管通路鞘套市場
  • 亞太地區
    • 主要市場趨勢和機遇
    • 日本輸尿管通路鞘套市場
    • 中國輸尿管通路鞘套市場
    • 澳洲輸尿管通路鞘套市場
    • 印度輸尿管通路鞘套市場
    • 韓國輸尿管通路鞘套市場
    • 其他亞太地區輸尿管通路鞘套市場
  • 拉丁美洲/中東/非洲
    • 主要市場趨勢和機遇
    • 巴西輸尿管通路鞘套市場
    • 沙烏地阿拉伯輸尿管通路鞘套市場
    • 南非輸尿管通路鞘套市場
    • 其他拉丁美洲/中東/非洲輸尿管通路鞘套市場

第7章 競爭格局

  • 介紹
  • 關鍵成功策略
  • 10家主要企業產品圖譜
  • 競爭對手儀表板
  • 競爭熱圖
  • 主要企業定位（2023年）

第8章 公司簡介

  • Boston Scientific Corporation
  • Cook Group
  • Coloplast Corp.
  • Olympus Corporation
  • Oscor Inc.
  • Karl Storz Endoscopy GmbH
  • Richard Wolf GmbH
  • COGENTIX MEDICAL
  • Becton, Dickinson And Company
  • Envaste Ltd
簡介目錄
Product Code: A66217

Ureteral Access Sheath Market

The ureteral access sheath market was valued at $1,293.6 million in 2023 and is estimated to reach $2,412.46 million by 2035, exhibiting a CAGR of 5.31% from 2024 to 2035

A ureteral access sheath is crucial equipment in urological procedures specifically used in interventions involving the urinary tract and kidneys. It is a flexible tube inserted into the ureter to form a path for other instruments, such as lasers and scopes, during minimally invasive surgeries such as ureteroscopy. The sheath enables repeated insertion and removal of instruments without causing any harm, which is beneficial in cases with multiple interventions or prolonged procedures. The easy access to the kidney and ureter offered by ureteral access sheath enables urologists to perform complex procedures with high precision and efficiency. According to research, ureteral access sheath lowers intraoperative intrarenal pressure and temperature by enhancing irrigation outflow during surgeries.

Increase in prevalence of kidney stone, developing healthcare infrastructure, and surge in adoption of minimally invasive procedures are the major drivers of the ureteral access sheath market. The cases of kidney stones have surged over the past few years due to unhealthy dietary habits and rise in obesity, dehydration, & metabolic disorders. As per a factsheet released by the Center of Disease Control and Prevention this year, around 6 million individuals are suffering from kidney stone in the U.S. Ureteral access sheaths play a crucial role in the treatment of such diseases, thereby witnessing a boost in demand.

However, the placement of ureteral access sheath is highly complex which requires significant training and practice. Incorrect placement usually leads to severe complications, hence constraining the market development. Moreover, there are several substitute approaches for the treatment of urinary diseases such as retrograde intrarenal surgery that do not use the sheath, hence limiting its adoption. Contrarily, according to a poster presented at the American Urological Association 2024 (AUA 2024) annual meeting, preoperative administration of tamsulosin, a medication which relaxes the prostate & bladder neck muscles, is able to successfully place the ureteral access sheath for treating kidney stones.

Segment Review

The global ureteral access sheath market is segmented into type, end user, and region. By type, the market is divided into Fr below 10, Fr 10-12, and Fr 13-15. On the basis of end user, it is classified into hospitals, specialty clinics, and ambulatory surgical centers. Region wise, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

Key Findings

By type, the Fr below 10 segment dominated the market in 2023.

On the basis of end user, the specialty clinics segment acquired a high market share in 2023.

In North America, the market is robust, owing to mature healthcare system, and significant investments in R&D.

Competition Analysis

The major players operating in the ureteral access sheath market are Boston Scientific, Cook Medical, Coloplast Corp, Olympus Corporation, Karl Storz, Oscor Inc, Richard Wolf, Cogentix Medical, Becton, Dickinson and Company, and Envaste Ltd. These players have adopted various key developmental strategies such as business expansion, new product launches, and partnerships to strengthen their foothold in the market.

Additional benefits you will get with this purchase are:

  • Quarterly Update and* (only available with a corporate license, on listed price)
  • 5 additional Company Profile of client Choice pre- or Post-purchase, as a free update.
  • Free Upcoming Version on the Purchase of Five and Enterprise User License.
  • 16 analyst hours of support* (post-purchase, if you find additional data requirements upon review of the report, you may receive support amounting to 16 analyst hours to solve questions, and post-sale queries)
  • 15% Free Customization* (in case the scope or segment of the report does not match your requirements, 15% is equivalent to 3 working days of free work, applicable once)
  • Free data Pack on the Five and Enterprise User License. (Excel version of the report)
  • Free Updated report if the report is 6-12 months old or older.
  • 24-hour priority response*
  • Free Industry updates and white papers.

Possible Customization with this report (with additional cost and timeline, please talk to the sales executive to know more)

  • Regulatory Guidelines
  • Additional company profiles with specific to client's interest
  • Additional country or region analysis- market size and forecast
  • Expanded list for Company Profiles
  • Historic market data
  • Key player details (including location, contact details, supplier/vendor network etc. in excel format)

Key Market Segments

By Type

  • Fr below 10
  • Fr 10-12
  • Fr 13-15

By End User

  • Hospital
  • Specialty Clinics
  • Ambulatory Surgical Centers

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Spain
    • Rest of Europe
  • Asia-Pacific
    • Japan
    • China
    • Australia
    • India
    • South Korea
    • Rest of Asia-Pacific
  • LAMEA
    • Brazil
    • Saudi Arabia
    • South Africa
    • Rest of LAMEA

Key Market Players:

    • Boston Scientific Corporation
    • Cook Group
    • Coloplast Corp.
    • Olympus Corporation
    • Oscor Inc.
    • Karl Storz Endoscopy GmbH
    • Richard Wolf GmbH
    • COGENTIX MEDICAL
    • Becton, Dickinson and Company
    • Envaste Ltd

TABLE OF CONTENTS

CHAPTER 1: INTRODUCTION

  • 1.1. Report Description
  • 1.2. Key Market Segments
  • 1.3. Key Benefits
  • 1.4. Research Methodology
    • 1.4.1. Primary Research
    • 1.4.2. Secondary Research
    • 1.4.3. Analyst Tools and Models

CHAPTER 2: EXECUTIVE SUMMARY

  • 2.1. CXO Perspective

CHAPTER 3: MARKET LANDSCAPE

  • 3.1. Market Definition and Scope
  • 3.2. Key Findings
    • 3.2.1. Top Investment Pockets
    • 3.2.2. Top Winning Strategies
  • 3.3. Porter's Five Forces Analysis
    • 3.3.1. Bargaining Power of Suppliers
    • 3.3.2. Threat of New Entrants
    • 3.3.3. Threat of Substitutes
    • 3.3.4. Competitive Rivalry
    • 3.3.5. Bargaining Power among Buyers
  • 3.4. Market Dynamics
    • 3.4.1. Drivers
    • 3.4.2. Restraints
    • 3.4.3. Opportunities

CHAPTER 4: URETERAL ACCESS SHEATH MARKET, BY TYPE

  • 4.1. Market Overview
    • 4.1.1 Market Size and Forecast, By Type
  • 4.2. Fr Below 10
    • 4.2.1. Key Market Trends, Growth Factors and Opportunities
    • 4.2.2. Market Size and Forecast, By Region
    • 4.2.3. Market Share Analysis, By Country
  • 4.3. Fr 10-12
    • 4.3.1. Key Market Trends, Growth Factors and Opportunities
    • 4.3.2. Market Size and Forecast, By Region
    • 4.3.3. Market Share Analysis, By Country
  • 4.4. Fr 13-15
    • 4.4.1. Key Market Trends, Growth Factors and Opportunities
    • 4.4.2. Market Size and Forecast, By Region
    • 4.4.3. Market Share Analysis, By Country

CHAPTER 5: URETERAL ACCESS SHEATH MARKET, BY END USER

  • 5.1. Market Overview
    • 5.1.1 Market Size and Forecast, By End User
  • 5.2. Hospital
    • 5.2.1. Key Market Trends, Growth Factors and Opportunities
    • 5.2.2. Market Size and Forecast, By Region
    • 5.2.3. Market Share Analysis, By Country
  • 5.3. Specialty Clinics
    • 5.3.1. Key Market Trends, Growth Factors and Opportunities
    • 5.3.2. Market Size and Forecast, By Region
    • 5.3.3. Market Share Analysis, By Country
  • 5.4. Ambulatory Surgical Centers
    • 5.4.1. Key Market Trends, Growth Factors and Opportunities
    • 5.4.2. Market Size and Forecast, By Region
    • 5.4.3. Market Share Analysis, By Country

CHAPTER 6: URETERAL ACCESS SHEATH MARKET, BY REGION

  • 6.1. Market Overview
    • 6.1.1 Market Size and Forecast, By Region
  • 6.2. North America
    • 6.2.1. Key Market Trends and Opportunities
    • 6.2.2. Market Size and Forecast, By Type
    • 6.2.3. Market Size and Forecast, By End User
    • 6.2.4. Market Size and Forecast, By Country
    • 6.2.5. U.S. Ureteral Access Sheath Market
      • 6.2.5.1. Market Size and Forecast, By Type
      • 6.2.5.2. Market Size and Forecast, By End User
    • 6.2.6. Canada Ureteral Access Sheath Market
      • 6.2.6.1. Market Size and Forecast, By Type
      • 6.2.6.2. Market Size and Forecast, By End User
    • 6.2.7. Mexico Ureteral Access Sheath Market
      • 6.2.7.1. Market Size and Forecast, By Type
      • 6.2.7.2. Market Size and Forecast, By End User
  • 6.3. Europe
    • 6.3.1. Key Market Trends and Opportunities
    • 6.3.2. Market Size and Forecast, By Type
    • 6.3.3. Market Size and Forecast, By End User
    • 6.3.4. Market Size and Forecast, By Country
    • 6.3.5. Germany Ureteral Access Sheath Market
      • 6.3.5.1. Market Size and Forecast, By Type
      • 6.3.5.2. Market Size and Forecast, By End User
    • 6.3.6. France Ureteral Access Sheath Market
      • 6.3.6.1. Market Size and Forecast, By Type
      • 6.3.6.2. Market Size and Forecast, By End User
    • 6.3.7. UK Ureteral Access Sheath Market
      • 6.3.7.1. Market Size and Forecast, By Type
      • 6.3.7.2. Market Size and Forecast, By End User
    • 6.3.8. Italy Ureteral Access Sheath Market
      • 6.3.8.1. Market Size and Forecast, By Type
      • 6.3.8.2. Market Size and Forecast, By End User
    • 6.3.9. Spain Ureteral Access Sheath Market
      • 6.3.9.1. Market Size and Forecast, By Type
      • 6.3.9.2. Market Size and Forecast, By End User
    • 6.3.10. Rest of Europe Ureteral Access Sheath Market
      • 6.3.10.1. Market Size and Forecast, By Type
      • 6.3.10.2. Market Size and Forecast, By End User
  • 6.4. Asia-Pacific
    • 6.4.1. Key Market Trends and Opportunities
    • 6.4.2. Market Size and Forecast, By Type
    • 6.4.3. Market Size and Forecast, By End User
    • 6.4.4. Market Size and Forecast, By Country
    • 6.4.5. Japan Ureteral Access Sheath Market
      • 6.4.5.1. Market Size and Forecast, By Type
      • 6.4.5.2. Market Size and Forecast, By End User
    • 6.4.6. China Ureteral Access Sheath Market
      • 6.4.6.1. Market Size and Forecast, By Type
      • 6.4.6.2. Market Size and Forecast, By End User
    • 6.4.7. Australia Ureteral Access Sheath Market
      • 6.4.7.1. Market Size and Forecast, By Type
      • 6.4.7.2. Market Size and Forecast, By End User
    • 6.4.8. India Ureteral Access Sheath Market
      • 6.4.8.1. Market Size and Forecast, By Type
      • 6.4.8.2. Market Size and Forecast, By End User
    • 6.4.9. South Korea Ureteral Access Sheath Market
      • 6.4.9.1. Market Size and Forecast, By Type
      • 6.4.9.2. Market Size and Forecast, By End User
    • 6.4.10. Rest of Asia-Pacific Ureteral Access Sheath Market
      • 6.4.10.1. Market Size and Forecast, By Type
      • 6.4.10.2. Market Size and Forecast, By End User
  • 6.5. LAMEA
    • 6.5.1. Key Market Trends and Opportunities
    • 6.5.2. Market Size and Forecast, By Type
    • 6.5.3. Market Size and Forecast, By End User
    • 6.5.4. Market Size and Forecast, By Country
    • 6.5.5. Brazil Ureteral Access Sheath Market
      • 6.5.5.1. Market Size and Forecast, By Type
      • 6.5.5.2. Market Size and Forecast, By End User
    • 6.5.6. Saudi Arabia Ureteral Access Sheath Market
      • 6.5.6.1. Market Size and Forecast, By Type
      • 6.5.6.2. Market Size and Forecast, By End User
    • 6.5.7. South Africa Ureteral Access Sheath Market
      • 6.5.7.1. Market Size and Forecast, By Type
      • 6.5.7.2. Market Size and Forecast, By End User
    • 6.5.8. Rest of LAMEA Ureteral Access Sheath Market
      • 6.5.8.1. Market Size and Forecast, By Type
      • 6.5.8.2. Market Size and Forecast, By End User

CHAPTER 7: COMPETITIVE LANDSCAPE

  • 7.1. Introduction
  • 7.2. Top Winning Strategies
  • 7.3. Product Mapping of Top 10 Player
  • 7.4. Competitive Dashboard
  • 7.5. Competitive Heatmap
  • 7.6. Top Player Positioning, 2023

CHAPTER 8: COMPANY PROFILES

  • 8.1. Boston Scientific Corporation
    • 8.1.1. Company Overview
    • 8.1.2. Key Executives
    • 8.1.3. Company Snapshot
    • 8.1.4. Operating Business Segments
    • 8.1.5. Product Portfolio
    • 8.1.6. Business Performance
    • 8.1.7. Key Strategic Moves and Developments
  • 8.2. Cook Group
    • 8.2.1. Company Overview
    • 8.2.2. Key Executives
    • 8.2.3. Company Snapshot
    • 8.2.4. Operating Business Segments
    • 8.2.5. Product Portfolio
    • 8.2.6. Business Performance
    • 8.2.7. Key Strategic Moves and Developments
  • 8.3. Coloplast Corp.
    • 8.3.1. Company Overview
    • 8.3.2. Key Executives
    • 8.3.3. Company Snapshot
    • 8.3.4. Operating Business Segments
    • 8.3.5. Product Portfolio
    • 8.3.6. Business Performance
    • 8.3.7. Key Strategic Moves and Developments
  • 8.4. Olympus Corporation
    • 8.4.1. Company Overview
    • 8.4.2. Key Executives
    • 8.4.3. Company Snapshot
    • 8.4.4. Operating Business Segments
    • 8.4.5. Product Portfolio
    • 8.4.6. Business Performance
    • 8.4.7. Key Strategic Moves and Developments
  • 8.5. Oscor Inc.
    • 8.5.1. Company Overview
    • 8.5.2. Key Executives
    • 8.5.3. Company Snapshot
    • 8.5.4. Operating Business Segments
    • 8.5.5. Product Portfolio
    • 8.5.6. Business Performance
    • 8.5.7. Key Strategic Moves and Developments
  • 8.6. Karl Storz Endoscopy GmbH
    • 8.6.1. Company Overview
    • 8.6.2. Key Executives
    • 8.6.3. Company Snapshot
    • 8.6.4. Operating Business Segments
    • 8.6.5. Product Portfolio
    • 8.6.6. Business Performance
    • 8.6.7. Key Strategic Moves and Developments
  • 8.7. Richard Wolf GmbH
    • 8.7.1. Company Overview
    • 8.7.2. Key Executives
    • 8.7.3. Company Snapshot
    • 8.7.4. Operating Business Segments
    • 8.7.5. Product Portfolio
    • 8.7.6. Business Performance
    • 8.7.7. Key Strategic Moves and Developments
  • 8.8. COGENTIX MEDICAL
    • 8.8.1. Company Overview
    • 8.8.2. Key Executives
    • 8.8.3. Company Snapshot
    • 8.8.4. Operating Business Segments
    • 8.8.5. Product Portfolio
    • 8.8.6. Business Performance
    • 8.8.7. Key Strategic Moves and Developments
  • 8.9. Becton, Dickinson And Company
    • 8.9.1. Company Overview
    • 8.9.2. Key Executives
    • 8.9.3. Company Snapshot
    • 8.9.4. Operating Business Segments
    • 8.9.5. Product Portfolio
    • 8.9.6. Business Performance
    • 8.9.7. Key Strategic Moves and Developments
  • 8.10. Envaste Ltd
    • 8.10.1. Company Overview
    • 8.10.2. Key Executives
    • 8.10.3. Company Snapshot
    • 8.10.4. Operating Business Segments
    • 8.10.5. Product Portfolio
    • 8.10.6. Business Performance
    • 8.10.7. Key Strategic Moves and Developments